For example, the HCV patients with hepatocellular carcinoma (HCC) shows significantly higher levels of serum HMGB1 relative to that of healthy controls (92.1 ± 50.6 ng/mL vs. 7.0 ± 5.9 ng/mL) [59]. Here, HMGB1 is linked to hepatocellular carcinoma.